21 C.F.R. § 866.3225

Enterovirus nucleic acid assay.

Last amended: 2016Year: 2026Length: 113 wordsSubsections: 1Official source

Cite as 21 C.F.R. § 866.3225 (2026)

(a) Identification. An enterovirus nucleic acid assay is a device that consists of primers, probes, enzymes, and controls for the amplification and detection of enterovirus ribonucleic acid (RNA) in cerebrospinal fluid (CSF) from individuals who have signs and symptoms consistent with meningitis or meningoencephalitis. The detection of enterovirus RNA, in conjunction with other laboratory tests, aids in the clinical laboratory diagnosis of viral meningitis caused by enterovirus. (b) Classification. Class II (special controls). The special control is FDA's guidance document entitled “Class II Special Controls Guidance Document: Nucleic Acid Amplification Assay for the Detection of Enterovirus RNA.” See § 866.1(e) for the availability of this guidance document. [74 FR 8, Jan. 2, 2009]
Cross-references to the CFR
866.1
21 C.F.R. § 866.3225: Enterovirus nucleic acid assay. | Justis AI